SE390969B - Forfarande for framstellning av 1,2,3,4-tetrahydro-7-halogen-6-sulfamyl-4-kinazolinoner - Google Patents

Forfarande for framstellning av 1,2,3,4-tetrahydro-7-halogen-6-sulfamyl-4-kinazolinoner

Info

Publication number
SE390969B
SE390969B SE6700024A SE2467A SE390969B SE 390969 B SE390969 B SE 390969B SE 6700024 A SE6700024 A SE 6700024A SE 2467 A SE2467 A SE 2467A SE 390969 B SE390969 B SE 390969B
Authority
SE
Sweden
Prior art keywords
chinazolinones
sulfamyl
tetrahydro
halogen
procedure
Prior art date
Application number
SE6700024A
Other languages
English (en)
Inventor
B V Shetty
Original Assignee
Wallace & Tiernan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallace & Tiernan Inc filed Critical Wallace & Tiernan Inc
Publication of SE390969B publication Critical patent/SE390969B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE6700024A 1966-01-03 1967-01-02 Forfarande for framstellning av 1,2,3,4-tetrahydro-7-halogen-6-sulfamyl-4-kinazolinoner SE390969B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US517995A US3360518A (en) 1966-01-03 1966-01-03 Tetrahydro-halo-sulfamyl quinazolinones

Publications (1)

Publication Number Publication Date
SE390969B true SE390969B (sv) 1977-01-31

Family

ID=24062092

Family Applications (1)

Application Number Title Priority Date Filing Date
SE6700024A SE390969B (sv) 1966-01-03 1967-01-02 Forfarande for framstellning av 1,2,3,4-tetrahydro-7-halogen-6-sulfamyl-4-kinazolinoner

Country Status (14)

Country Link
US (1) US3360518A (sv)
AT (2) AT286989B (sv)
BE (1) BE692082A (sv)
BR (1) BR6785894D0 (sv)
CH (1) CH515910A (sv)
DE (1) DE1620740C3 (sv)
DK (1) DK134113B (sv)
ES (1) ES334560A1 (sv)
FI (1) FI51350C (sv)
FR (1) FR6844M (sv)
GB (1) GB1170790A (sv)
IL (1) IL27126A (sv)
NL (1) NL149493B (sv)
SE (1) SE390969B (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458513A (en) * 1967-11-02 1969-07-29 Wallace & Tiernan Inc 2-substituted-tetrahydro-halosulfamyl-quinazolinones
US3452020A (en) * 1967-11-09 1969-06-24 Wallace & Tiernan Inc 2-alkenyl and 2-alkynyl substituted - tetrahydro - halo-sulfamyl-quinazolinones
US3452019A (en) * 1967-11-16 1969-06-24 Wallace & Tiernan Inc 1-phenylalkyl-tetrahydro-halo-sulfamyl-quinazolinone
US3518267A (en) * 1968-02-23 1970-06-30 Pennwalt Corp 1-aminoalkyl and 1-hydroxyalkyl-tetrahydro-halo-sulfamyl-quinazolinone
US3549629A (en) * 1968-02-29 1970-12-22 Pennwalt Corp 2 - substituted or unsubstituted carboxy tetrahydro - halo - sulfamyl-quinazolinones
US3549636A (en) * 1968-02-29 1970-12-22 Pennwalt Corp 2-alkanoyl,alkanoylalkyl,alkanoyloxyalkyl,and hydroxyalkyl substituted tetrahydro - halo - sulfamyl- quinazolinones
US3549634A (en) * 1968-03-28 1970-12-22 Pennwalt Corp 8,5 - amino - substituted - tetrahydrohalo-sulfamyl-quinazolinones
US3541096A (en) * 1968-12-24 1970-11-17 Pennwalt Corp 2-aryl-substituted-tetrahydro-halo-sulfamyl-quinazolinones
ZA732937B (en) * 1972-05-05 1974-03-27 Maggioni & C Spa Non mercurial diuretics
EP0057763A1 (en) * 1981-01-26 1982-08-18 Pennwalt Corporation Improved process for the preparation of 2-methyl-3-(o-tolyl)-7-chloro-1,2,3,4-tetrahydro-4-oxo-6-quinazolinesulfonamide
US4522818A (en) * 1982-10-14 1985-06-11 Pennwalt Corporation Diuretic/antihypertensive compositions
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US5264439A (en) * 1990-02-13 1993-11-23 Merck & Co., Inc. Quinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl element
US5633240A (en) * 1994-09-01 1997-05-27 Academic Pharmaceuticals Parenteral solutions containing metolazone
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
DK1336407T3 (da) * 2000-11-21 2006-09-04 Sankyo Co Præparat indeholdende en angiotensin-II-receptorantagonist og et diuretikum og anvendelse deraf til behandling af hypertension
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
US20080275093A1 (en) * 2004-11-15 2008-11-06 Nitromed, Inc. Diuretic Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
ES2847904T3 (es) 2013-07-23 2021-08-04 Daiichi Sankyo Co Ltd Medicamento para la prevención o el tratamiento de la hipertensión
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US11248001B2 (en) 2019-01-18 2022-02-15 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976289A (en) * 1961-03-21 X-tetrahydro -
GB1464445A (en) * 1973-02-19 1977-02-16 Mitsubishi Electric Corp Apparatus for making a printing master
ATE15950T1 (de) * 1982-06-04 1985-10-15 Hell Rudolf Dr Ing Gmbh Verfahren zur vermeidung von bildfehlern beim mehrfarbendruck, die durch fehlerhaften uebereinanderdruck der farbauszuege entstehen.
GB8410860D0 (en) * 1984-04-27 1984-06-06 Crosfield Electronics Ltd Image modification

Also Published As

Publication number Publication date
DK134113C (sv) 1977-02-14
US3360518A (en) 1967-12-26
CH515910A (de) 1971-11-30
NL149493B (nl) 1976-05-17
FI51350B (sv) 1976-08-31
AT291269B (de) 1971-07-12
AT286989B (de) 1971-01-11
GB1170790A (en) 1969-11-19
NL6700083A (sv) 1967-07-04
DK134113B (da) 1976-09-13
ES334560A1 (es) 1967-11-01
DE1620740C3 (de) 1979-05-10
IL27126A (en) 1972-01-27
BE692082A (sv) 1967-06-16
BR6785894D0 (pt) 1973-12-27
FR6844M (sv) 1969-04-08
FI51350C (sv) 1976-12-10
DE1620740B2 (de) 1978-09-14
DE1620740A1 (de) 1970-05-21

Similar Documents

Publication Publication Date Title
SE390969B (sv) Forfarande for framstellning av 1,2,3,4-tetrahydro-7-halogen-6-sulfamyl-4-kinazolinoner
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE380792B (sv) Forfarande for framstellning av substituerade fenylalkanolaminen
SE409708B (sv) Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidiner
SE381041B (sv) Forfarande for framstellning av aminoguanidiner
FI48722C (sv) Förfarande för framställning av 3-metylpentener.
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
DOP1972002000A (es) Procedimiento para la preparacion de nuevas benzacepinas.
SE397971B (sv) Forfarande for framstellning av halogenmetyl-1,3-polyhalogen-2-propyletrar
SE416201B (sv) Foerfarande foer framstaellning av 1,4-bensodiazepinderivat
DK131429B (da) Analogifremgangsmåde til fremstilling af derivater af 4'-demethyl-epipodophyllotoxin-beta-D-glucosid.
SE333146B (sv) Foerfarande foer framstaellning av pyrazinoyl-och pyrazinamidoguanidiner
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al
SE343301B (sv) Foerfarande foer framstaellning av 5-klor-2,3-pyridindiol
FI44593C (fi) Menetelmä d(-)-pantolaktonin valmistamiseksi
SE380531B (sv) Forfarande for framstellning av 13-alkyl-1,3,5(10),6,8,14-steroidhexaener
NO136976C (no) Fremgangsm}te for fremstilling av 2,3-dihydrobenzodiazepiner
SE398878B (sv) Forfarande for framstellning av substituerade 2,4-diamino-5-bensylpyrimidiner
SE343292B (sv) Foerfarande foer framstaellning av vissa angivna bensofenoniminer
FI43733C (fi) Menetelmä alfa-6-deoksitetrasykliinien valmistamiseksi
FI49714C (sv) Förfarande för framställning av 5-bensylpyrimidiner.
IT954006B (it) Procedimento per la preparazione di 1 2 4 ditiazolidine
FI48600C (sv) Förfarande för framställning av aminopenicilliner.
SE394277B (sv) Forfarande for framstellning av 6,7-bensomorfanderivat
DK120845B (da) Fremgangsmåde til fremstilling af 3β-formoxy-15α-halogen-14β-hydroxy-5β-card-20(22)-enolider.